| Date | Title | Description |
| 24.10.2024 | AMSilk and Ajinomoto Join Forces to Advance Bio-Based Silk Proteins for High-Performance, Biodegradable Textiles | German biotech company AMSilk GmbH has entered into a long-term partnership with Ajinomoto Foods Europe, an affiliate of the Ajinomoto Group, to manufacture biobased silk proteins at large scale for biodegradable textiles.
The collaboration... |
| 04.10.2024 | Qure.ai: $65 Million (Series D) Raised To Expand Into More Markets | Mumbai-based global healthcare AI company Qure.ai announced it raised a $65 million Series D funding round. This funding round will expedite expansion in the US market and other geographies, invest more in foundational AI models, and enable... |
| 27.09.2024 | Qure.ai raises Series D funding led by Lightspeed, 360 ONE Asset | Prashant Warier, co-founder and chief executive, Qure.ai
Qure.ai Technologies Pvt. Ltd, a health-tech startup that uses artificial intelligence for medical imaging diagnostics, has raised $65 million ( Rs 544 crore) in Series D funding roun... |
| 27.09.2024 | Global healthcare AI startup Qure.ai raises $65M in Series D round led by Lightspeed and 360One Asset
Recommended Stories For You | AI-driven healthcare startup Qure.ai has raised $65 million in its Series D funding round. The round was led by Lightspeed and 360 ONE Asset, with participation from Merck Global Health Innovation Fund and Kae Capital. Existing investors su... |
| 27.09.2024 | Lightspeed and 360 ONE Asset Lead USD 65 Mn Series D Funding for Qure.ai's Global Healthcare AI Expansion With the raised funds, Qure.ai aims to expand in the US and global markets, advance AI models,... | AI-driven healthcare startup Qure.ai has raised USD 65 million in its Series D funding round led by Lightspeed and 360 ONE Asset, with participation from other prominent investors such as Merck Global Health Innovation Fund and Kae Capital.... |
| 26.09.2024 | Qure.ai, a Global Healthcare AI Innovator, Raises $65 Million in Series D Funding Led by Lightspeed and 360One Asset | Qure.ai, a global healthcare AI innovator, has announced the completion of a $65 million Series D funding round. The investment will expedite expansion into the US market and other geographies, increase investment into foundational AI model... |
| 26.09.2024 | Qure.ai Closes $65M Series D Funding | Qure.ai, a Mumbai, India-based healthcare AI innovator, raised $65M in Series D funding.
The round was led by Lightspeed and 360 ONE Asset, joined by Merck Global Health Innovation Fund and Kae Capital. Existing investors Novo Holdings, Hea... |
| 25.09.2024 | Qure.ai Raises $65M to Expand Healthcare AI Solutions Globally | What You Should Know:
– Qure.ai, a prominent global innovator in healthcare AI, has successfully closed a $65M in Series D funding round led by Lightspeed and 360 ONE Asset, with contributions from Merck Global Health Innovation Fund and Ka... |
| 16.09.2024 | Denmark’s Matr Foods Secures €20M EU Loan for Mycelium Meat Factory | 4 Mins Read Danish meat analogue startup Matr Foods has received €20M in debt funding from the European Investment Bank to open a large-scale mycelium meat facility.
Mycelium meat maker Matr Foods has received a €20M loan from the EU’s lend... |
| 13.09.2024 | MATR Foods Secures €20M From European Investment Bank to Construct First Full-Scale Facility | Danish meat alternatives producer MATR Foods has signed a €20 million loan agreement with the European Investment Bank (EIB).
The funding, which is supported by the European Commission’s InvestEU initiative, will allow MATR to construct its... |
| 31.08.2024 | Catalent delays filing of annual report | Healthcare & PharmaceuticalsCommercial Strategy
Catalent delays filing of annual report
By ReutersAugust 30, 20249:32 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A general view of the dr... |
| 28.07.2024 | The Surge of Innovation: How Magenta Medical and Brenig Therapeutics are Shaping the Future of Healthcare | In the world of healthcare, innovation is the lifeblood that keeps the industry thriving. Two companies, Magenta Medical and Brenig Therapeutics, are at the forefront of this revolution. With significant funding rounds recently completed, t... |
| 26.07.2024 | Magenta Medical: Heart Pump Company Raises $105 Million | Magenta Medical, the developer of Elevate (the world’s smallest heart pump), announced it had closed a $105 million funding round led by global healthcare investment firm Novo Holdings. The new investors Viking Global Investors and RA Capit... |
| 18.07.2024 | Asceneuron's $100M Series C Funding Boosts Alzheimer's Disease Research | Asceneuron, a Lausanne-based clinical-stage biotech company, has recently announced the successful completion of a $100 million Series C financing round. This significant funding boost, led by Novo Holdings and supported by EQT Life Science... |
| 16.07.2024 | Asceneuron closes $100 million series C financing round |
Asceneuron SA, a Lausanne-based clinical-stage biotech company developing small molecules targeting tau protein aggregation, a root cause of neurodegenerative disease, announces its $100 million oversubscribed Series C financing round. The... |
| 16.07.2024 | EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round | EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round
Tue, Jul 16, 2024 09:15 CET Report this content
EQT Life Sciences has invested in Asceneuron’s oversubscr... |
| 15.07.2024 | Temasek aims to invest up to $10 bn in India over three years | Credit: Reuters
Singapore state investor Temasek plans to invest up to $10 billion in India over three years in sectors such as financial services and healthcare, a top executive said on Monday, favouring the South Asian nation as it turns ... |
| 10.07.2024 | Future Food Quick Bites: Crownless Pineapples, Spent Coffee Cookies & A Brat Summer | 6 Mins Read In our weekly column, we round up the latest news and developments in the alternative protein and sustainable food industry. This week, Future Food Quick Bites covers Aldi’s zero-waste pineapples, a Charli XCX-inspired marketing... |
| 08.07.2024 | Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development | London, UK, 8 July 2024 – Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), today announced the closing of its series A financi... |
| 03.07.2024 | Novo Holdings Invests in MATR Foods’ Fungi-Powered Fermented Meat Alternatives | Life science investor Novo Holdings has announced an initial investment in MATR Foods, a Danish food tech startup leveraging the power of mycelium, traditional fermentation, and upcycled vegetables to make sustainable meat alternative produ... |
| 02.07.2024 | AI-based agritech firm AgNext Technologies receives investment from Novo | Novo Holdings, an investor based in Denmark, revealed that it had taken the lead in funding AgNext Technologies Private Limited, an agricultural and food technology company based in India that innovates artificial intelligence-based technol... |
| 25.06.2024 | Novo Holdings invests in Indian agritech firm AgNext Technologies | Copenhagen-based life sciences investor Novo Holdings has invested an undisclosed sum in Indian agritech player AgNext Technologies Private Limited to support the latter’s growth and international expansion.
The deal marks Novo Holdings’s f... |
| 25.06.2024 | Healthcare-focussed Novo Holdings bets on homegrown agritech firm | Premium
Kasim Kutay, CEO, Novo Holdings | Credit: Reuters/Ali Withers
Danish investor Novo Holdings, which has primarily invested in healthcare companies in India and owns a majority stake in weight-loss drugmaker Novo Nordisk, has invested... |
| 14.06.2024 | Ex-Groupon CEO raises $411 million in IPO for medicine data company | figcaption>span]:font-sans" data-chromatic="ignore">
Tempus AI, a Chicago-based provider of data and analytics tools for precision medicine developers, raised $411 million in its IPO.
Why it matters: You probably didn't... |
| 28.05.2024 | Johnson & Johnson acquires Numab spin-off for USD 1.25 billion |
Numab Therapeutics AG based in Horgen (ZH) is developing multi-specific antibody-based immunotherapies for inflammation and cancer. Johnson & Johnson will acquire global rights to Numabs lead molecule NM26, a Phase 2-ready investigatio... |
| 23.05.2024 | Enifer's Groundbreaking Journey: A New Era in Mycoprotein Production | Enifer, a pioneering Finnish biotech startup, has recently made waves in the protein industry by securing an impressive €36 million in funding. This substantial investment is set to fuel the construction of a state-of-the-art mycoprotein fa... |
| 23.05.2024 | Novo Holdings Boston office named a 2024 Best Place to Work by the Boston Business Journal | - Investment firm's connection to the Novo Nordisk Foundation provides a strong sense of purpose, report employees
- Award highlights collaborative, respectful workplace, and comprehensive employee benefits
BOSTON, May 23, 2024 /PRNewswire/... |
| 23.05.2024 | Finnish biotech Enifer secures €36 million to cope with the world’s soaring protein need | - |
| 22.05.2024 | Pioneering Sustainability: CIRCTEC's €150M Funding Injection for Revolutionary Tyre Recycling Facility | In a groundbreaking move towards sustainable waste management, CIRCTEC, a trailblazer in pyrolysis technology for end-of-life tyre recycling, has secured a monumental €150 million in funding. This significant investment, spearheaded by indu... |
| 22.05.2024 | CIRCTEC secures €150M to construct Europe’s largest end-of-life tyre pyrolysis recycling facility in the Netherlands | Read this article in:
UK-based CIRCTEC, a company specialising in pyrolysis for sustainable end-of-life tyre recycling, announced on Tuesday, May 21, that it has secured €150M in a fresh financing round co-led by Novo Holdings and A.P. Moll... |
| 01.05.2024 | Britt Meelby Jensen nominated to Hempel A/S Board of Directors | Britt Meelby Jensen nominated to Hempel A/S Board of Directors
Wed, May 01, 2024 10:00 CET Report this content
Chief Executive Officer (CEO) of Ambu A/S, Britt Meelby Jensen, has been nominated to replace Susanna Schneeberger as board membe... |
| 01.05.2024 | Investiții de 188 milioane EUR, pregătite de gigantul pharma Novo Nordisk pentru startup-uri de tehnologii cuantice | Gigantul farmaceutic danez Novo Nordisk, cunoscut mai ales pentru medicamentele Wegovy și Ozempic folosite în tratamentul diabetului și obezității, a anunțat miercuri că va investi până la 188 de milioane EUR (1,4 miliarde coroane daneze) î... |
| 12.04.2024 | Healthcare M&A Volume Falls in Q1:24, According to Acquisition Data from LevinPro HC | LevinPro HC
Healthcare merger and acquisition activity declined by 4% in the first quarter of 2024, according to new acquisition data from LevinPro HC. Deal volume in Q1:24 only reached 494 deals, falling short of the 515 transactions annou... |
| 04.04.2024 | Denmark’s REDUCED bags €6M to convert food and agriculture side streams into natural ingredients | Read this article in:
Copenhagen-based REDUCED, a company specialising in converting food and agriculture side streams into natural food ingredients through fermentation has secured €6M in funding.
The investment came from a range of invest... |
| 20.03.2024 | Startup Lands $150M for Delicate Dance Between Cancer Cells & Immune Cells | Cancer immunotherapy comes in several forms, and one area of growing research interest is a type of drug called a T cell engager. These drugs bind to a cancer cell and a T cell simultaneously, bringing both of them together to spark a thera... |
| 06.02.2024 | Vertex still knows how to do what it does best | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hello, everyone. Damian here with a close read of the latest blockbuster deal, a look at Novartis’ multibillion-doll... |
| 11.12.2023 | INDACO VENTURE PARTNERS – HOBA THERAPEUTICS RAISES EUR 23 MILLION IN A SERIES A TO ADVANCE NEW DRUG CANDIDATE AGAINST CHORNIC NEUROPATHIC PAIN | |
| 23.10.2023 | Which VCs are investing in rare diseases? | Firms include Chiesi Ventures, Frazier Healthcare Partners, OrbiMed, and Atlas Venture
In the United States alone 25 million people suffer from rare disease, a number that jumps to 400 million people globally. While 1 in 10 people will suff... |
| 06.10.2023 | Flush with Wegovy cash, Novo Nordisk's owner widens investment strategy beyond biotech | Outside of a global pandemic, it’s rare for a medicine to truly become a household name. But Novo Nordisk’s Wegovy is rapidly reaching that status, with the obesity drug accruing more front pages and celebrity endorsers every day.
The succe... |
| 17.08.2023 | Novo Holdings participates in $290m strategic financing of Sangon Biotech | COPENHAGEN, Denmark, Aug. 17, 2023 /PRNewswire/ -- Novo Holdings, a leading international life science investor, today announced it has participated in a $290 million (USD) strategic financing round of Sangon Biotech. Sangon is a leading pr... |
| 09.08.2023 | Bactolife's €30M in funding to commercialise gut health binding proteins | Danish biotech Bactolife develops Binding Proteins to help strengthen the gut microbiome of humans and animals. The Copenhagen-based company, which was founded in 2017, is boosting gut health at an affordable price, lowering the risk of inf... |
| 08.08.2023 | Copenhagen-based Bactolife raises €30M to bring exclusive ‘Binding Proteins’ to market to improve gut health | Read this article in:
Copenhagen-based bio-industrial firm Bactolife announced that it has raised over €30M in a Series A round of funding. The round was led by ATHOS, with participation from the Bill & Melinda Gates Foundation and exis... |
| 21.06.2023 | EQT Private Equity to sell Ellab, following transformation into a leading validation & monitoring provider for the Biotech and Pharmaceutical industries | EQT Private Equity to sell Ellab, following transformation into a leading validation & monitoring provider for the Biotech and Pharmaceutical industries
Wed, Jun 21, 2023 08:00 CET Report this content
EQT Private Equity, together with i... |
| 13.04.2023 | Alentis Therapeutics closes USD 105 million Series C round | |
| 15.03.2023 | All smiles as Fire1 raises $25 million for heart failure recovery | Dublin-based medtech firm Fire1, has announced the close of a $25 million financing round to accelerate the development of its monitoring solution to improve outcomes for heart failure patients.
The round was led by new investors Andera Par... |
| 06.03.2023 | Chromologics raises additional funding, bringing the series seed to a total of EUR 12.6 M, and welcomes two new investors Doehler Ventures and Thia Ventures. | Chromologics raises additional funding, bringing the series seed to a total of EUR 12.6 M, and welcomes two new investors Doehler Ventures and Thia Ventures.
Mon, Mar 06, 2023 08:15 CET Report this content
The proceeds of EUR 7.1 M will be ... |
| 06.03.2023 | Nordic Foodtech VC invests in Chromologics during €12.6M seed round | Nordic Foodtech VC invests in Chromologics during €12.6M seed round
06 March, 2023, 11:30
Rostyslav Sobachynskyi --> --> --> -->--> --> --> --> --> --> --> --> -->
Finnish fund Nordic Foodtech VC ha... |
| 17.01.2023 | LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management | LePure Biotech is a leading provider of high-quality and innovative single-use bioprocessing solutions in China
Proceeds will be used to continue to accelerate product innovation and advance LePure Biotech's go-to-market strategy
SHANGHAI, ... |
| 09.01.2023 | Denmark’s Evosep bags €37.4M to advance the use of proteins in clinical diagnosis | Denmark-based Evosep, the bioscience company that claims to be leading the standardisation of proteomics for clinical use, announced on Monday that it has raised $40M (approximately €37.48M) in a fresh round of funding.
Evosep aims to impro... |
| 21.12.2022 | Doctor Anywhere acquires Singapore-listed Asian Healthcare Specialists, secures additional US$38.8 million funding | Acquisition of integrated healthcare provider Asian Healthcare Specialists marks expansion of strategic capabilities, builds holistic healthcare offering to serve Southeast Asia
SINGAPORE – Media OutReach – 21 December 2022 – Doctor Anywher... |
| 03.11.2022 | Roslin Technologies Raises £11m in Series A funding round | Edinburgh-based food and agritech firm Roslin Technologies has completed a Series A funding round led by Novo Holdings.
The £11 million investment will support the company’s next phase of growth as it aims to become a “leading provider” of ... |
| 22.09.2022 | The Week in Agrifoodtech: Swiftly bags $100m for grocery tech, Pano’s $20m to fight wildfires with AI | This week, retail and grocery tech startup Swiftly bagged a mega-round while front-of-house restaurant software startup Zenchef cooked up new financing to expand its presence. In agtech, Pano raised funds to fight wildfires with AI and Land... |
| 30.08.2022 | MedGenome Raises $50 Mn To Expand Global Footprint, Scale Up SaaS Offerings | The funding round was led by Novo Holdings, with participation from existing investors such as LeapFrog Investments and Sofina
MedGenome will use the funding to expand its geographical footprint beyond South Asia to Africa and the Middle Ea... |
| 30.06.2022 | FMC buys BioPhero for $200m to boost biologicals portfolio, hints at further acquisitions | US agribusiness major FMC has agreed to acquire BioPhero, a Danish startup producing pheromone-based biocontrols for the crop-growing industry.
An FMC statement said that the company will buy BioPhero for “approximately” $200 million.
BioPh... |
| 16.05.2022 | BREAKING: Vestaron banks $82m Series C funding for its crop-protecting peptides | US biotech startup Vestaron, which is devleoping biological alternatives to chemical-based crop controls using peptides, has raised $82 million in its Series C funding round.
Private investment officer Ordway Selections and Cavallo Ventures... |
| 03.05.2022 | Engimmune Therapeutics raises CHF 15.5 million in seed financing | |
| 29.03.2022 | Healthtech Startup Qure.ai Bags $40 Mn Funding To Disrupt Radiology ‘Status Quo’ | Healthtech startup, Qure.ai, has raised $40 Mn in a strategic funding round led by Novo Holdings and HealthQuad.
The fundraise also saw participation from existing investor MassMutual Ventures.
The startup will use the funding to expand its... |
| 29.03.2022 | Unlocking food’s dark matter | It is often said that the food system is broken.
It is not broken.
Instead, it was designed over time to effectively and efficiently produce and distribute safe, inexpensive, and highly caloric food. While hunger has been materially reduced... |
| 09.02.2022 | Novo Holdings to acquire Medical Knowledge Group | January 3, 2022: Novo Holdings A/S (“Novo Holdings”), a leading global life sciences investor, today announced that it has agreed to acquire Medical Knowledge Group from Court Square Capital and Aisling Capital.
Medical Knowledge Group (“M... |
| 14.01.2022 | Verana Health Raises $150M to Expand Real-World Data Network | What You Should Know:
Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights from an exclusive real-world data network, today announced a $150 million Series E funding round led by Johnson... |
| 12.01.2022 | Tribune Therapeutics Launches to Develop Novel Medicines Targeting a Wide Range of Fibrotic Diseases | Company co-created and funded by HealthCap and Novo Holdings
– Breakthrough asset in-licensed from Norway’s foremost tech transfer office, Inven2
– Jonas Hansson, Partner, HealthCap will assume the role of Executive Chairman as Georg Vo B... |
| 11.01.2022 | Shanghai ZhenGe Biotech Raises USD 100 million Round C Led by Goldman Sachs Asset Management and Sofina | SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Shanghai ZhenGe Biotech Co., Ltd. ("ZhenGe Biotech" or "the Company") announced the completion of round C financing of US $100 million, led by Goldman Sachs Asset Management and So... |
| 11.01.2022 | Shanghai ZhenGe Biotech Raises USD 100 million Round C Led by Goldman Sachs Asset Management and Sofina | SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Shanghai ZhenGe Biotech Co., Ltd. ("ZhenGe Biotech" or "the Company") announced the completion of round C financing of US $100 million, led by Goldman Sachs Asset Management and So... |
| 23.12.2021 | Cincinnati plays host to new cell, viral vector manufacturing site from Expression Therapeutics | Expression Therapeutics’ new cell and viral vector manufacturing site is up and running in Cincinnati.
The 43,000 square-foot site will provide end-to-end R&D capabilities and both early phase- and commercial-scale ... |
| 23.12.2021 | Arrowhead adds newest facility to its Midwest hub in RNAi drug production push | Arrowhead Pharmaceuticals has purchased 13 acres of land in Wisconsin’s Verona Technology Park and will build a 140,000-square-foot drug manufacturing facility.
The company will spend between $200 million and $250 mil... |
| 23.12.2021 | FDA authorizes new Merck Covid-19 pill despite scientists' concerns on its mechanism of action | A Danish bio industrial scale-up company has landed an $86 million investment from Novo Holdings, and it’s hoping to build on a technology base from Novozymes. And with that investment will come a new manufacturing site.
21st.BIO was founde... |
| 31.08.2021 | Digital Health Platform Doctor Anywhere Closes S$88 Million Series C Round to Deepen Southeast Asia Expansion | The company has experienced a 500 percent growth in the business since the start of 2020.
The investment will significantly bolster DA's market leadership and its mission to transform the regional healthcare landscape through technology.
SI... |
| 30.06.2021 | Anterra Capital Announces Initial Closing of Second Agrifoodtech Fund at $175M |
Anterra Capital , the international agrifood VC firm and investor partner of StartLife, announced the initial closing of its second food and agriculture technology fund, Anterra F&A Ventures II. With $175 million they exceeded the tar... |
| 27.05.2021 | Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings | SINGAPORE, May 26, 2021 /PRNewswire/ -- Esco Lifesciences ("Esco", the "Company") announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Nov... |
| 27.05.2021 | Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings | SINGAPORE, May 27, 2021 /PRNewswire/ -- Esco Lifesciences ("Esco", the "Company") announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Nov... |
| 26.05.2021 | Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings | |
| 20.05.2021 | Numab Therapeutics Completes CHF 100 Million Series C Financing | |
| 20.05.2021 | Numab Therapeutics Completes CHF 100 Million Series C Financing | Numab Therapeutics aims to write the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. Its lead product was designed to balance potent anti-tumor immunity wit... |
| 18.05.2021 | Hummingbird Bioscience Raises US$125 Million in Series C Financing | Investment round led by Novo Holdings, joined by a syndicate of international biotech investors
Proceeds will support advancement of Hummingbird's lead assets in clinical trials and building of its next-generation portfolio of precision the... |
| 18.05.2021 | Hummingbird Bioscience : Raises US$125 Million in Series C Financing | Investment round led by Novo Holdings, joined by a syndicate of international biotech investors
Proceeds will support advancement of Hummingbird's lead assets in clinical trials and building of its next-generation portfolio of precision the... |
| 17.05.2021 | Hummingbird Bioscience Raises US$125 Million in Series C Financing | |
| 11.05.2021 | PRESS RELEASE : AMSilk raises EUR 29M to accelerate commercialization of its high-performance bio-based silk polymers | DGAP-News: AMSilk GmbH / Key word(s): Financing AMSilk raises EUR 29M to accelerate commercialization of its high-performance bio-based silk polymers 2021-05-11 / 10:22 The issuer is solely responsible for the content of this announcement. ... |
| 29.04.2021 | Ysios Capital lidera una inversión de €51 millones en Adcendo. Acuden también Novo Seeds, RA Capital Management, HealthCap y Gilde | 29/04/2021
Nota de prensa
YSIOS CAPITAL LIDERA UNA INVERSIÓN DE €51 MILLONES EN ADCENDO.
− Adcendo (Copenhague, Dinamarca), es una compañía biotecnológica especializada en el desarrollo de fármacos inmunoconjugados para el tratamiento de... |
| 29.04.2021 | Ysios Capital leads a €51M round in Adcendo, also followed up by Novo Seeds, RA Capital Management, HealthCap and Gilde | ADCENDO RAISES €51 MILLION IN SERIES A FINANCING TO ADVANCE NOVEL ANTIBODY-DRUG CONJUGATES FOR TREATMENT OF CANCERS.
Financing led by Novo Seeds and Ysios Capital is largest Series A for a Danish biotech company
Plans to build a pipeline o... |
| 09.03.2021 | Pest pheromone startup BioPhero nets $17m in DCVC-led Series A | BioPhero, a Danish startup that’s fermenting insect pheromones for crop protection purposes, has just raised $17 million in Series A funding.
The round was led by DCVC Bio, the life sciences-focused fund under Silicon Valley-based DCVC. FMC... |
| 09.03.2021 | BREAKING: Pest pheromone startup BioPhero nets $17m in DCVC-led Series A | BioPhero, a Danish startup that’s fermenting insect pheromones for crop protection purposes, has just raised $17 million in Series A funding.
The round was led by DCVC Bio, the life sciences-focused fund under Silicon Valley-based DCVC. FMC... |
| 10.12.2020 | What’s coming up at MedCity INVEST Precision Medicine Day 3? | The MedCity INVEST Precision Medicine healthcare conference on December 9-11 draws healthcare and life science executives and investors as we spotlight progress in the development of diagnostics, clinical trial innovation, AI in drug develo... |
| 24.11.2020 | Mark your calendars for our virtual INVEST Precision Medicine conference, December 9-11 | What Does the Diagnostics Landscape Look Like?
Diagnostics is joined at the hip with precision medicine. The rapidly evolving field has led to the ability to quickly, reliably and affordably sequence an individual’s entire genome and the de... |
| 17.11.2020 | MycoWorks banks $45m Series B funding; DCVC, AgFunder & celebs invest | MycoWorks, which produces an animal-free leather alternative, has raised $45 million in a Series B round co-led by Taiwan’s WTT Investment and California’s DCVC Bio.
New investors included Valor Equity Partners, Humboldt Fund, and Gruss &am... |
| 11.11.2020 | The Protein Brewery raises $26m from pea protein maker Roquette, Novo Nordisk affiliate | The Protein Brewery, a Netherlands-based fermentation tech company working on replacements for animal proteins, has raised €22 million ($26 million) in its Series A round.
Novo Growth led the round. It’s the VC arm of Novo Holdings, a Danis... |
| 05.11.2020 | Dutch Fermentation Specialist ‘The Protein Brewery’ Raises €22M to Feed the World With Fungi | The Protein Brewery, a developer of sustainable, fermented proteins, announces a €22M Series A investment round led by Novo Growth. Referring to themselves as “masters in brewing proteins”, the Dutch scientists focus on integrating animal-f... |
| 19.10.2020 | VectivBio secures $110 million to finance Phase III clinical trials | VectivBio closed a $110 million crossover financing from new investors Surveyor Capital (a Citadel company), Cormorant Capital and Eventide Asset Management, with participation from existing investors Versant Ventures, OrbiMed, Novo Holding... |
| 19.10.2020 | VectivBio secures $110 million to finance Phase III clinical trials | |
| 01.09.2020 | The Crunchbase News Briefing: Tues., Sept. 1 | 10 Shares Email Facebook Twitter LinkedIn
Here’s what you need to know today in startup and venture news, updated by the Crunchbase News staff throughout the day to keep you in the know. Owl Ventures raises $585M for edtech
Owl Ventures, a ... |
| 13.08.2020 | Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform | What You Should Know:
– Mission Bio raises $70 million in Series C funding led by Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
– Mission Bio’s Tapestri Platform, the first single-cell platform ... |
| 09.01.2020 | Therachon spin-off launches with $35 million investment | VectivBio, a clinical-stage biotechnology company, is bringing transformational medicines to patients with serious rare diseases. The company announced its formation with $35 million in financing including commitments by Versant Ventures, O... |
| 09.01.2020 | Therachon spin-off launches with $35 million investment | |
| 17.09.2019 | Boulder’s Edgewise Therapeutics closes $50 million Series B financing | Edgewise Therapeutics, a Boulder company working to develop new therapies for treating patients with debilitating musculoskeletal disease, announced the closing of a $50 million Series B financing round on Tuesday.
The funding will help the... |
| 13.09.2019 | Anokion raises $40 million and acquires US biotech startup | |
| 06.08.2019 | Through a new partnership and $72 million in funding, LanzaTech expands its carbon capture tech | For nearly 15 years LanzaTech has been developing a carbon capture technology that can turn waste streams into ethanol that can be used for chemicals and fuel.
Now, with $72 million in fresh funding at a nearly $1 billion valuation and a ne... |
| 14.06.2019 | Vestaron Closes $40m Series B for Peptide-based Biopesticide with “Proven Modes of Action Unlike Microbials,” says CEO | From AgFunder News by Lauren Stine |
| 13.06.2019 | Vestaron Closes $40m Series B for Peptide-based Biopesticide with “Proven Modes of Action Unlike Microbials,” says CEO | Vestaron wants farmers to know that its peptide-based products are different from existing microbial products, offering more consistent efficacy with the same environmental benefits.
Peptide-based biopesticide company Vestaron closed a $40 ... |
| 11.06.2019 | Vestaron Announces Series B Financing | With its proprietary platform for the optimization and production of peptide-based biopesticides, Vestaron is leading the development of a novel class of crop protection products – peptides (small proteins) that have the proven modes of act... |
| 27.09.2018 | Syngenta Ventures invests in $2.9m seed round for pheromone pest control startup BioPhero | Danish ag biotech startup BioPhero closed a $2.9 million seed round with Syngenta Ventures, Novo Seeds, the early-stage investment arm of life sciences investor Novo Holdings, and Danish public innovation hub Syddansk Innovation.
The compan... |
| 09.08.2018 | Therachon Raises $60 Million Mezzanine Financing | |
